Avid Bioservices Names Richard Richieri as Chief Operations Officer
October 09, 2019 12:30 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Completion of Expansion of Process Development Capabilities and Laboratory Infrastructure
October 08, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Termination of Stockholder Rights Plan
September 23, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Reports Financial Results for First Quarter Fiscal 2020 and Recent Developments
September 05, 2019 16:05 ET
|
Avid Bioservices, Inc
-- Achieved First Quarter Revenue of $15.3 Million; Reaffirms Fiscal 2020 Projected Revenue of $64 to $67 Million -- -- Signed Two Contract Manufacturing Agreements with New and Existing Customers --...
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
September 04, 2019 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Cytovance Biologics to Participate in Boston’s BioProcess International Convention
August 30, 2019 08:10 ET
|
Cytovance Biologics
OKLAHOMA CITY, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate...
Avid Bioservices to Report Financial Results For First Quarter of Fiscal Year 2020 After Market Close on September 5, 2019
August 29, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Avid Bioservices Announces Appointment of Catherine Mackey, Ph.D. to Board of Directors
July 26, 2019 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., July 26, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to...
Erythropoietin (EPO) Drugs Market To Cross USD 12 billion by 2020 | Reports And Data
July 24, 2019 09:51 ET
|
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Erythropoietin (EPO) Drugs market offers an extensive analysis of the trends to estimate its growth in the near future. It provides...
Avid Bioservices Enters into Contract Manufacturing Agreements with New and Existing Customers
July 08, 2019 08:05 ET
|
Avid Bioservices, Inc
Company Signs Top Ten Global Pharmaceutical Company as New Client and Expands Relationship with Existing Biotechnology Company Customer Agreements Include Process Transfer, Process Development and...